Chicago Partners Investment Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Sell |
20,658
-19
| -0.1% | -$985 | 0.03% | 381 |
|
|
2025
Q1 | $885K | Sell |
20,677
-4,523
| -18% | -$194K | 0.03% | 382 |
|
|
2024
Q4 | $659K | Hold |
25,200
| – | – | 0.02% | 435 |
|
|
2024
Q3 | $722K | Hold |
25,200
| – | – | 0.03% | 399 |
|
|
2024
Q2 | $671K | Hold |
25,200
| – | – | 0.03% | 397 |
|
|
2024
Q1 | $529K | Hold |
25,200
| – | – | 0.02% | 430 |
|
|
2023
Q4 | $551K | Hold |
25,200
| – | – | 0.03% | 405 |
|
|
2023
Q3 | $304K | Hold |
25,200
| – | – | 0.02% | 504 |
|
|
2023
Q2 | $1.13M | Sell |
25,200
-1,146
| -4% | -$51.5K | 0.06% | 275 |
|
|
2023
Q1 | $1.18M | Buy |
26,346
+352
| +1% | +$15.8K | 0.07% | 239 |
|
|
2022
Q4 | $1.18M | Sell |
25,994
-4,206
| -14% | -$191K | 0.07% | 240 |
|
|
2022
Q3 | $1.15M | Hold |
30,200
| – | – | 0.08% | 219 |
|
|
2022
Q2 | $309K | Hold |
30,200
| – | – | 0.02% | 432 |
|
|
2022
Q1 | $264K | Hold |
30,200
| – | – | 0.02% | 440 |
|
|
2021
Q4 | $548K | Hold |
30,200
| – | – | 0.04% | 316 |
|
|
2021
Q3 | $749K | Hold |
30,200
| – | – | 0.05% | 272 |
|
|
2021
Q2 | $657K | Hold |
30,200
| – | – | 0.05% | 282 |
|
|
2021
Q1 | $912K | Hold |
30,200
| – | – | 0.08% | 210 |
|
|
2020
Q4 | $938K | Hold |
30,200
| – | – | 0.09% | 187 |
|
|
2020
Q3 | $833K | Hold |
30,200
| – | – | 0.1% | 161 |
|
|
2020
Q2 | $1.15M | Hold |
30,200
| – | – | 0.14% | 118 |
|
|
2020
Q1 | $621K | Hold |
30,200
| – | – | 0.1% | 165 |
|
|
2019
Q4 | $595K | Hold |
30,200
| – | – | 0.07% | 198 |
|
|
2019
Q3 | $636K | Hold |
30,200
| – | – | 0.09% | 171 |
|
|
2019
Q2 | $676K | Buy |
+30,200
| New | +$676K | 0.1% | 153 |
|